Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Datta, Milton W."'
Autor:
Sanchez, Pilar, Hernández, Ana Maria, Stecca, Barbara, Kahler, Andrea J., DeGueme, Amy M., Barrett, Andrea, Beyna, Mercedes, Datta, Milton W., Datta, Sumana, Scott, Matthew P.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2004 Aug . 101(34), 12561-12566.
Externí odkaz:
https://www.jstor.org/stable/3373022
Autor:
Mesa, Hector, Gilles, Scott, Datta, Milton W., Murugan, Paari, Larson, Wendy, Dachel, Susan, Manivel, Juan C.
Publikováno v:
In Human Pathology March 2017 61:181-189
Autor:
Iczkowski, Kenneth A., Egevad, Lars, Ma, Jun, Harding-Jackson, Nicholas, Algaba, Ferran, Billis, Athanase, Camparo, Philippe, Cheng, Liang, Clouston, David, Comperat, Eva M., Datta, Milton W., Evans, Andrew G., Griffiths, David F., Guo, Charles C., Hailemariam, Seife, Huang, Wei, Humphrey, Peter A., Jiang, Zhong, Kahane, Hillel, Kristiansen, Glen, La Rosa, Francisco G., Lopez-Beltran, Antonio, MacLennan, Gregory T., Magi-Galluzzi, Cristina, Merrimen, Jennifer, Montironi, Rodolfo, Osunkoya, Adeboye O., Picken, Maria M., Rao, Nagarjun, Shah, Rajal B., Shanks, Jonathan H., Shen, Steven S., Tawfik, Ossama W., True, Lawrence D., Van der Kwast, Theodorus, Varma, Murali, Wheeler, Thomas M., Zynger, Debra L., Sahr, Natasha, Bostwick, David G.
Publikováno v:
In Annals of Diagnostic Pathology December 2014 18(6):333-342
Autor:
Young, Andrew N., Dale, Jennifer, Yin-Goen, Qiqin, Harris, Wayne B., Petros, John A., Datta, Milton W., Wang, May D., Marshall, Fray F., Amin, Mahul B.
Publikováno v:
In Urology 2006 67(5):873-880
Autor:
Melamed Jonathan, Berman Jules J, Datta Milton W, Gupta Rajnish, Dhir Rajiv, Parwani Anil V, Gilbertson John R, Patel Ashokkumar A, Kajdacsy-Balla Andre, Orenstein Jan, Becich Michael J
Publikováno v:
BMC Cancer, Vol 6, Iss 1, p 120 (2006)
Abstract Background Advances in molecular biology and growing requirements from biomarker validation studies have generated a need for tissue banks to provide quality-controlled tissue samples with standardized clinical annotation. The NCI Cooperativ
Externí odkaz:
https://doaj.org/article/b73870a3e3a146e5b8fe063724ec3624
Autor:
Farach-Carson Cindy, Shah Rajal B, Dhir Rajiv, DeGueme Amy M, Kahler Andrea J, Schlicht Michael J, Hernandez Ana, Datta Milton W, Barrett Andrea, Datta Sumana
Publikováno v:
Molecular Cancer, Vol 5, Iss 1, p 9 (2006)
Abstract Background Genetic studies associated the CAPB locus with familial risk of brain and prostate cancers. We have identified HSPG2 (Perlecan) as a candidate gene for CAPB. Previously we have linked Perlecan to Hedgehog signaling in Drosophila.
Externí odkaz:
https://doaj.org/article/9330f273ecaa4e7d90f0c57c03080fb7
Publikováno v:
In Modern Pathology 1 May 2001 14(5):437-442
Autor:
Melamed Jonathan, Gilbertson John, Dhir Rajiv, Datta Milton W, Bosland Maarten, Berman Jules J, Kajdacsy-Balla André, Patel Ashokkumar A, Orenstein Jan, Tai Kuei-Fang, Becich Michael J
Publikováno v:
BMC Cancer, Vol 5, Iss 1, p 108 (2005)
Abstract Background The Cooperative Prostate Cancer Tissue Resource (CPCTR) is a consortium of four geographically dispersed institutions that are funded by the U.S. National Cancer Institute (NCI) to provide clinically annotated prostate cancer tiss
Externí odkaz:
https://doaj.org/article/79b1b0df355f48e79bcdb7e0c4d047eb
Autor:
Dhir Rajiv, Zhou Guohui, Liu Hang, Wen Xinyu, Brodzeller Tracy, Matysiak Brian, Schlicht Michael, Hessner Martin J, Tonellato Peter, Suckow Mark, Pollard Morris, Datta Milton W
Publikováno v:
BMC Genomics, Vol 5, Iss 1, p 58 (2004)
Abstract Background Gene expression technologies have the ability to generate vast amounts of data, yet there often resides only limited resources for subsequent validation studies. This necessitates the ability to perform sorting and prioritization
Externí odkaz:
https://doaj.org/article/f07a2aa2079a49be9b9ef3d355c84cea
Autor:
Liao Zhongyue, Datta Milton W
Publikováno v:
BMC Urology, Vol 4, Iss 1, p 8 (2004)
Abstract Background Prostate cancer is the most common tumor in men. The most commonly used diagnostic and tumor recurrence marker is Prostate Specific Antigen (PSA). After surgical removal or radiation treatment, PSA levels drop (PSA nadir) and subs
Externí odkaz:
https://doaj.org/article/1f5b36b2e3f948ca9ef128baade1c35d